The U.S. House Republicans have advanced what is seen by many as a provision that will kill hemp in a bill of appropriations for the fiscal year 2026.
On June 23, the House Appropriations Committee approved the budget by a 35-27 vote, along party lines. Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Bill. The spending bill, which is 138 pages long, includes over $25 billion of discretionary funding to help address the many issues that face U.S. rural communities and farmers.
The bill this year includes language that will rewrite rules for hemp-derived cannabinoid product. This provision is intended to respond to what law enforcement and elected officials have increasingly seen as a concern for public safety and health in light of the federal legalization by the 2018 Farm Bill of industrial hemp production. The 2018 Farm Bill only regulates industrial hemp as a commodity, not the finished goods that contain its derivatives.
Under the Appropriation Committee’s fiscal 2026 legislation, hemp-derived cannabinoid products containing synthetic compounds and/or quantifiable amounts of THC or THCA—or other cannabinoids that have similar effects on humans or animals—would be illegal.
When the legislation first advanced through the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration (FDA), on June 5, Rep. Andy Harris, R-Md., said he was hoping to close the “hemp loophole” in the 2018 Farm Bill that has resulted in the proliferation of intoxicating cannabinoid products, such as those that contain delta-8 THC.
Harris, who is the chairman of the subcommittee has provided similar Opening remarks The full markup of the committee is shown below.
Harris explained that, “Many states are now taking action to stop these products, especially harmful ones, from reaching the public, and this is a good time for Congress, to take steps to protect industrial hemp while closing this loophole.” “Reports that the included language would destroy legitimate businesses are simply not true—and that is clear to anyone closely reading the carefully drafted language that threaded the needle.”
Harris was accused by the U.S. Hemp Roundtable earlier this month for “reviving” his crusade to “quietly dismantle” the hemp industry. This is done through burying on page 113 the language that defines hemp in such a way as “to ban the vast majority” of legal, safe hemp products that are sold across the country.
Industry advocacy groups argued that if the bill included language prohibiting products with “quantifiable quantities” of THC and THCA, it would effectively ban most CBD products.
Renée Johnson, a specialist in agricultural policy with the nonpartisan Congressional Research Service (CRS), authored a June 13 report On the Appropriations Bill that supported that claim, the writer wrote that “excluding hemp derived cannabinoid product from the federal definition would effectively prohibit production and sales of hemp derived cannabinoids and derivatives and extracts of them, including CBD.”
However, a This version is updated Johnson’s CRS was published June 20, omitting any reference to CBD.
It is much more costly to produce hemp products that contain a pure CBD isolate, which filters out any trace amount of THC. Under the 2018 Farm Bill hemp can have up to 0.3% Delta-9 THC in dry weight during an pre-harvest test. The rules for finished products would be altered if the potency threshold was removed.
The House Appropriations Committee has approved the a Manager’s Amendment Harris, on 11 June, clarified the fact that the “committee does not intend industrial and nonintoxicating hemp-derived cannabinoid product with trace or minimal amounts of THC will be impacted.”
According to the legislation, it is up to Secretary of Health and Human Services of United States of America (HHS) determines what constitutes “quantifiable quantities” of THC and other cannabinoids. The definition of industrial hemp would include the non-cannabinoid uses such as fiber, grain, and other products.
Not all business associations are opposed to the purpose of the Appropriations Bill.
American Trade Association of Cannabis and Hemp stands by the statement. principle Intoxicating products available to consumers should be controlled in order to promote public safety, and the growth of the cannabis industry.
Michael Bronstein, ATACH’s President in a press release dated June 23rd said: “The 2018 Farm Bill has set the stage to the proliferation of THC-derived synthetic products.” Cannabis Business Times. The House Appropriations Committee took an important action today to address the dangers posed by products containing synthetic THC. It also created clear regulatory paths for products derived from hemp and closed legal loopholes.
The Congress must address the risks of synthetic products that are chemically altered, protect CBD and ensure parity between all natural THC-based products, regardless of their origin. Looking forward to continue working with Congress on creating a unified federal frame work for all natural THC product.
Harris’ draft for the Agriculture/FDA Spending Bill fiscal 2025 included similar language on hemp, but was removed later from last year’s appropriations bill.
Now, the House will be able to enjoy this year’s version.
House Republicans in the United States have advanced a measure that many believe will eliminate hemp from the market. This is a part of a fiscal 2026 appropriations package which must be passed.
On June 23, the House Appropriations Committee approved the budget by a 35-27 vote, along party lines. Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Bill. The spending bill, which is 138 pages long, includes over $25 billion of discretionary funding to help address the many issues that face U.S. rural communities and farmers.
The bill this year includes language that will rewrite rules for hemp-derived cannabinoid product. This provision is intended to respond to what law enforcement and elected officials have increasingly seen as a concern for public safety and health in light of the federal legalization by the 2018 Farm Bill of industrial hemp production. The 2018 Farm Bill only regulates industrial hemp as a commodity, not the finished products that contain its derivatives.
Under the Appropriation Committee’s fiscal 2026 legislation, hemp-derived cannabinoid products containing synthetic compounds and/or quantifiable amounts of THC or THCA—or other cannabinoids that have similar effects on humans or animals—would be illegal.
When the legislation first advanced through the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration (FDA), on June 5, Rep. Andy Harris, R-Md., said he was hoping to close the “hemp loophole” in the 2018 Farm Bill that has resulted in the proliferation of intoxicating cannabinoid products, such as those that contain delta-8 THC.
Harris, who is the chairman of the subcommittee has provided similar Opening remarks The full markup of the committee is shown below.
Harris stated that “many states have taken action to prevent these harmful products reaching children and consumers. It’s now time for Congress act in order to close this gap while protecting the hemp industrial industry.” “Reports that the included language would destroy legitimate businesses are simply not true—and that is clear to anyone closely reading the carefully drafted language that threaded the needle.”
Harris, according to the U.S. Hemp Roundtable in an earlier statement this month, “revived his crusade,” to “quietly demolish” the hemp sector by hiding language on the page 113 proposed spending bill which would define hemp as a means of banning “the vast majority of safe and legal hemp-derived goods sold throughout the United States.”
According to the industry advocate organization, by including language that prohibits products with “quantifiable” amounts of THC or THCA in products it would effectively ban all non-intoxicating CBD.
Renée Johnson, a specialist in agricultural policy with the nonpartisan Congressional Research Service (CRS), authored a June 13 report The appropriations act that supports this claim states that: “Including hemp-derived products that are cannabinoids from federal definitions of hemp would prevent the production and sale hemp-derived derivatives or extracts including CBD.”
Then, there is also an This version is updated Johnson’s CRS Report was published by the CRS on 20 June, excluding any mention of CBD.
The cost of manufacturing hemp products with purified CBD is higher. According to the 2018 Farm Bill (the Farm Bill), hemp may contain as much as 0.3% delta-9 THC by dry weight in a field test conducted before harvest. The rules for finished products would be altered if the potency threshold was removed.
The House Appropriations Committee has approved the a Manager’s Amendment On June 11, Harris clarified that “the committee did not intend to affect industrial hemp cannabinoid-derived products with trace amounts or small amounts of THC.”
According to the legislation, it is up to Secretary of Health and Human Services of United States of America (HHS) determines what constitutes “quantifiable quantities” of THC and other cannabinoids. The definition of industrial hemp would include the non-cannabinoid uses such as fiber, grain, and other products.
Not all business associations are opposed to the purpose of the Appropriations Bill.
American Trade Association of Cannabis and Hemp stands by the statement. principle To improve the safety of consumers and to encourage growth in the cannabis sector, it is important that all products intoxicating be made available.
Michael Bronstein, ATACH’s President in a press release dated June 23, said that “the 2018 Farm Bill has set the stage to the proliferation of THC-synthetic products.” Cannabis Business Times. The House Appropriations Committee’s decision today is a first important step in addressing risks associated with synthetic THC, creating clear regulatory pathways for hemp-derived product, and closing legal loopholes.
The Congress must address the risks of synthetic products that are chemically altered, protect CBD and ensure parity between all natural THC-based products, regardless of their origin. Looking forward to continue working with Congress on creating a unified federal frame work for all natural THC product.
Harris’ draft for the Agriculture/FDA Spending Bill fiscal 2025 included similar language on hemp, but was removed later from last year’s appropriations bill.
Now, the House will be able to enjoy this year’s version.
Cannabis Law Resources in Poland
Browse essential legal pages on cannabis sales and cultivation in Poland. These guides will help you understand the legal requirements, such as certifications, permits, and compliance.
-
Polish News Registration and Interests of Cannabis Businesses
-
Permissions for Cannabis Sales in Poland
-
Authorization for Importing or Manufacturing Medical Products
-
Permission for Manufacturing or Importing Medical Products
-
Certificate of Good Manufacturing Practices (GMP)
-
Registration of Medical Products in Poland